BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16143483)

  • 1. Pharmacokinetics and metabolism of 1,5-dicaffeoylquinic acid in rats following a single intravenous administration.
    Yang B; Meng ZY; Yan LP; Dong JX; Zou LB; Tang ZM; Dou GF
    J Pharm Biomed Anal; 2006 Feb; 40(2):417-22. PubMed ID: 16143483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic profile of 1,5-dicaffeoylquinic acid in rats, an in vivo and in vitro study.
    Yang B; Meng Z; Dong J; Yan L; Zou L; Tang Z; Dou G
    Drug Metab Dispos; 2005 Jul; 33(7):930-6. PubMed ID: 15802385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of 1,5-dicaffeoylquinic acid and its active metabolites in human plasma by liquid chromatography-tandem mass spectrometry for pharmacokinetic studies.
    Gu R; Dou G; Wang J; Dong J; Meng Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):85-91. PubMed ID: 17267301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orally administered rosmarinic acid is present as the conjugated and/or methylated forms in plasma, and is degraded and metabolized to conjugated forms of caffeic acid, ferulic acid and m-coumaric acid.
    Baba S; Osakabe N; Natsume M; Terao J
    Life Sci; 2004 May; 75(2):165-78. PubMed ID: 15120569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended glucuronidation is another major path of cyanidin 3-O-beta-D-glucopyranoside metabolism in rats.
    Ichiyanagi T; Shida Y; Rahman MM; Hatano Y; Konishi T
    J Agric Food Chem; 2005 Sep; 53(18):7312-9. PubMed ID: 16131148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption and enterohepatic circulation of baicalin in rats.
    Xing J; Chen X; Zhong D
    Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of metabolites of tanshinone IIA in rats by liquid chromatography/tandem mass spectrometry.
    Li P; Wang GJ; Li J; Hao HP; Zheng CN
    J Mass Spectrom; 2006 May; 41(5):670-84. PubMed ID: 16598708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of (-)-epicatechin metabolites and their metabolic fate in the rat.
    Okushio K; Suzuki M; Matsumoto N; Nanjo F; Hara Y
    Drug Metab Dispos; 1999 Feb; 27(2):309-16. PubMed ID: 9929521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of three isomeric metabolites of tacrolimus (FK506) in human whole blood and plasma using high performance liquid chromatography-tandem mass spectrometry.
    Chen YL; Hirabayashi H; Akhtar S; Pelzer M; Kobayashi M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):330-41. PubMed ID: 16318929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
    Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
    Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
    Prakash C; Cui D; Potchoiba MJ; Butler T
    Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and metabolism of [14C]brasofensine in rats, monkeys, and humans.
    Zhu M; Whigan DB; Chang SY; Dockens RC
    Drug Metab Dispos; 2008 Jan; 36(1):24-35. PubMed ID: 17908924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic determination and pharmacokinetic study of vitexin-2''-O-rhamnoside in rat plasma after intravenous administration.
    Ying X; Gao S; Zhu W; Bi Y; Qin F; Li X; Li F
    J Pharm Biomed Anal; 2007 Jul; 44(3):802-6. PubMed ID: 17459645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of metabolites in rat plasma after intravenous administration of salvianolic acid A by liquid chromatography/time-of-flight mass spectrometry and liquid chromatography/ion trap mass spectrometry.
    Shen Y; Wang X; Xu L; Liu X; Chao R
    Rapid Commun Mass Spectrom; 2009 Jun; 23(12):1810-6. PubMed ID: 19437443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry.
    Liu Z; Huang L; Dai M; Chen D; Wang Y; Tao Y; Yuan Z
    Rapid Commun Mass Spectrom; 2008 Apr; 22(7):1009-16. PubMed ID: 18320546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the metabolites of roxithromycin in humans.
    Zhong D; Li X; Wang A; Xu Y; Wu S
    Drug Metab Dispos; 2000 May; 28(5):552-9. PubMed ID: 10772634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of four active alkaloids from a traditional Chinese medicine Corydalis saxicola Bunting. (Yanhuanglian) in plasma and urine samples by LC-MS-MS.
    Li HL; Zhang WD; Liu RH; Zhang C; Han T; Wang XW; Wang XL; Zhu JB; Chen CL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):140-6. PubMed ID: 16356790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism, distribution, and excretion of a next generation selective estrogen receptor modulator, lasofoxifene, in rats and monkeys.
    Prakash C; Johnson KA; Schroeder CM; Potchoiba MJ
    Drug Metab Dispos; 2008 Sep; 36(9):1753-69. PubMed ID: 18515329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography/mass spectrometric analysis of rat samples for in vivo metabolism and pharmacokinetic studies of ginsenoside Rh2.
    Qian T; Cai Z; Wong RN; Jiang ZH
    Rapid Commun Mass Spectrom; 2005; 19(23):3549-54. PubMed ID: 16261639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme.
    Kassahun K; McIntosh I; Cui D; Hreniuk D; Merschman S; Lasseter K; Azrolan N; Iwamoto M; Wagner JA; Wenning LA
    Drug Metab Dispos; 2007 Sep; 35(9):1657-63. PubMed ID: 17591678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.